A

Agilemd

www.agilemd.com link_icon

Company Research Report on AgileMD, Inc.



Company Overview



  • Name: AgileMD, Inc.

  • Mission: AgileMD aims to enhance clinical outcomes and reduce clinical burden through predictive analytics and standardized guidelines. Their solutions leverage advanced AI to offer early warnings for clinical deterioration, thus making electronic health records (EHR) work effectively for healthcare teams.

  • Founded: 2011

  • Founder/Key People: The document does not provide specific information about the founder or key people within AgileMD.

  • Headquarters: 2261 Market Street #4378, San Francisco, CA 94114-1600, United States

  • Number of Employees: No information is available.

  • Revenue: No information is available.

  • Known For: AgileMD is known for its FDA-cleared AI products, including eCART™ for early warning and workflow integration to predict clinical deterioration. It provides highly-integrated guidance through clinical pathways that are actionable and adaptable to various healthcare settings.


Products



eCART™



  • Description: eCART™ is a Clinical Deterioration Early Warning and Workflow tool designed to improve patient outcomes by predicting and prioritizing clinical deterioration.

  • Key Features:

  • FDA Cleared: Approved for predicting deterioration across conditions like sepsis, heart failure, COPD, and COVID.

  • Acuity-Based Workflow: Supports caregivers by providing better information on patient status.

  • Early Risk Stratification: Helps in timely ICU transfers, potentially decreasing hospital mortality and length of stay by over 2 days.

  • Validated Performance: Tested and validated through extensive research across multiple health systems.


Clinical Pathways



  • Description: Clinical Pathways provide adaptable guidance that integrates with existing hospital workflows for evidence-based practice.

  • Key Features:

  • Integration with EHR: Seamlessly embeds into Electronic Health Records for consistent practice standards.

  • Customization: Allows custom development of workflows tailored to local clinical needs.

  • Application Coverage: Wide-ranging topics in adult, pediatric, neonate, ambulatory, emergency, and women's health settings.

  • Outcome Achievements: Supported by over 20 journal articles validating operational and outcome improvements.


Recent Developments



  • New Products Launched: AgileMD received FDA clearance for its eCART suites to predict clinical deterioration.

  • Partnerships:

  • BARDA Partnership: Collaborated on deploying EHR-integrated software for COVID-19 patient identification.

  • Awards:

  • Phase II NIH SBIR Grant: Awarded $2M for developing eCART as a clinical decision support tool.

  • Operational Enhancements:

  • Yale New Haven Health System Study: Documented wide variation in hospital early warning systems performance.

  • Technological Advancements: AgileMD's technology has been implemented in over 250 hospitals with significant patient encounters, demonstrating rapid and seamless deployment.


No additional new features to existing products were disclosed in the provided content.

Conclusion


AgileMD stands out as a platform that blends advanced AI with clinical workflows for effective patient management. Although specific details on company revenue and key personnel are unavailable, AgileMD's commitment to transforming healthcare delivery through cutting-edge technologies and robust partnerships, like those with FDA and BARDA, continue to affirm its leadership position in the healthcare IT space.